Ingalls & Snyder LLC Buys 700 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ingalls & Snyder LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.1% during the third quarter, HoldingsChannel.com reports. The firm owned 5,035 shares of the medical equipment provider’s stock after purchasing an additional 700 shares during the quarter. Ingalls & Snyder LLC’s holdings in Intuitive Surgical were worth $2,474,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the stock. Integrated Wealth Concepts LLC boosted its position in shares of Intuitive Surgical by 1.9% in the third quarter. Integrated Wealth Concepts LLC now owns 4,821 shares of the medical equipment provider’s stock valued at $2,369,000 after acquiring an additional 90 shares during the period. Investment Management Corp of Ontario lifted its stake in Intuitive Surgical by 35.5% in the 3rd quarter. Investment Management Corp of Ontario now owns 14,494 shares of the medical equipment provider’s stock worth $7,120,000 after purchasing an additional 3,800 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in Intuitive Surgical by 1.4% in the 3rd quarter. Janus Henderson Group PLC now owns 689,939 shares of the medical equipment provider’s stock valued at $338,948,000 after purchasing an additional 9,727 shares during the period. Hilltop Holdings Inc. grew its position in Intuitive Surgical by 63.6% during the third quarter. Hilltop Holdings Inc. now owns 8,160 shares of the medical equipment provider’s stock worth $4,009,000 after buying an additional 3,172 shares in the last quarter. Finally, Ascent Group LLC lifted its position in Intuitive Surgical by 76.0% during the third quarter. Ascent Group LLC now owns 5,451 shares of the medical equipment provider’s stock valued at $2,678,000 after purchasing an additional 2,353 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, General Counsel Gary Loeb sold 300 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares of the company’s stock, valued at approximately $757,625. This represents a 15.83 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 51,023 shares of company stock valued at $26,384,247. 0.80% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts recently issued reports on ISRG shares. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $522.00 to $650.00 in a research note on Monday. Mizuho increased their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Royal Bank of Canada raised their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $536.61.

Intuitive Surgical Trading Down 1.5 %

ISRG traded down $8.34 during midday trading on Tuesday, reaching $534.51. The company’s stock had a trading volume of 79,208 shares, compared to its average volume of 1,444,128. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $552.00. The firm has a market capitalization of $190.38 billion, a price-to-earnings ratio of 87.28, a PEG ratio of 5.33 and a beta of 1.38. The stock’s 50-day moving average is $510.03 and its 200-day moving average is $469.49.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.